Propeller Health Raises $20M
Propeller Health announced today that it has raised $20 million to support its investment in its pipeline of digital therapeutics and additional connected devices for the treatment of chronic respiratory disease….
Category Archives: Biotech
BioForward Adds Eight to Board
Eight new members were voted onto the BioForward board of directors, the organization announced today. Serving a 2018-20 term from Madison are University of Wisconsin School of Medicine and Public Health…
FluGen Begins M2SR Clinical Trial
FluGen announced today it has dosed its first patients in a clinical trial of a novel investigational influenza vaccine called M2SR against multi-season mismatched strains, in Belgium. “If successful, the results from…
Cellectar Granted RPDD by FDA
Cellectar Biosciences announced today that the U.S. Food and Drug Administration has granted rare pediatric disease designation (RPDD) to its phospholipid drug conjugate, CLR 131, for the treatment of neuroblastoma….
Study Shows Propeller Reduces Asthma Burden
Propeller Health’s respiratory management system was used to reduce asthma burden in a recent study published in the healthcare journal Health Affairs, the company announced recently. According to a release,…
Cellectar Biosciences Nets Patent
The U.S. Patent and Trademark Office has awarded Cellectar Biosciences a patent (No. P150207US03) that covers a method of use for CLR 131 in multiple myeloma, the company announced today….
Exact Sciences Names Cologuard President
Exact Sciences named Mark Stenhouse as president of Cologuard, its noninvasive stool DNA-based test for early detection of colon cancer, the company announced recently. “More than 85 million people are…
Cellectar Receives Orphan Drug Designation
Cellectar Biosciences has been granted orphan drug designation for its therapeutic, CLR 131, by the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development for the treatment of neuroblastoma,…
Exact Sciences Adds Co-Chief Medical Officer
Exact Sciences named Paul J. Limburg, M.D., M.P.H., as its co-chief medical officer, the company announced today. “Dr. Limburg’s valuable mix of cancer prevention experience in both the clinical and…
One Million Screened Using Cologuard
Exact Sciences’ Cologuard has been used in more than one million screenings for colorectal cancer, the company announced today. “Approximately half of Cologuard users haven’t been screened before, and we’re…
